###begin article-title 0
Liver-Specific Deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) Improves Metabolic Syndrome and Attenuates Diet-Induced Endoplasmic Reticulum Stress
###end article-title 0
###begin p 1
###xml 37 57 37 57 <email xmlns:xlink="http://www.w3.org/1999/xlink">kbence@vet.upenn.edu</email>
###xml 83 107 83 107 <email xmlns:xlink="http://www.w3.org/1999/xlink">m.delibegovic@abdn.ac.uk</email>
Corresponding authors: Kendra Bence, kbence@vet.upenn.edu, and Mirela Delibegovic, m.delibegovic@abdn.ac.uk
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 453 456 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
OBJECTIVE-The protein tyrosine phosphatase PTP1B is a negative regulator of insulin signaling; consequently, mice deficient in PTP1B are hypersensitive to insulin. Because PTP1B-/- mice have diminished fat stores, the extent to which PTP1B directly regulates glucose homeostasis is unclear. Previously, we showed that brain-specific PTP1B-/- mice are protected against high-fat diet-induced obesity and glucose intolerance, whereas muscle-specific PTP1B-/- mice have increased insulin sensitivity independent of changes in adiposity. Here we studied the role of liver PTP1B in glucose homeostasis and lipid metabolism.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-We analyzed body mass/adiposity, insulin sensitivity, glucose tolerance, and lipid metabolism in liver-specific PTP1B-/- and PTP1Bfl/fl control mice, fed a chow or high-fat diet.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
RESULTS-Compared with normal littermates, liver-specific PTP1B-/- mice exhibit improved glucose homeostasis and lipid profiles, independent of changes in adiposity. Liver-specific PTP1B-/- mice have increased hepatic insulin signaling, decreased expression of gluconeogenic genes PEPCK and G-6-Pase, enhanced insulin-induced suppression of hepatic glucose production, and improved glucose tolerance. Liver-specific PTP1B-/- mice exhibit decreased triglyceride and cholesterol levels and diminished expression of lipogenic genes SREBPs, FAS, and ACC. Liver-specific PTP1B deletion also protects against high-fat diet-induced endoplasmic reticulum stress response in vivo, as evidenced by decreased phosphorylation of p38MAPK, JNK, PERK, and eIF2alpha and lower expression of the transcription factors C/EBP homologous protein and spliced X box-binding protein 1.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-Liver PTP1B plays an important role in glucose and lipid metabolism, independent of alterations in adiposity. Inhibition of PTP1B in peripheral tissues may be useful for the treatment of metabolic syndrome and reduction of cardiovascular risk in addition to diabetes.
###end p 6
###begin p 7
Published ahead of print at  on 15 December 2008.
###end p 7
###begin p 8
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
###end p 8
###begin p 9
###xml 219 220 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 221 222 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 646 647 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
In response to nutrients, insulin is secreted from pancreatic beta-cells directly into the portal circulation, where it promotes the storage of energy in the fed state and is the major regulator of glucose homeostasis (1,2). Insulin affects many components of hepatic carbohydrate and lipid metabolism, including glycogen synthesis, lipogenesis, and gluconeogenesis. These effects are achieved by modification of key molecular targets, either by reversible phosphorylation or by alteration of gene expression. Insulin promotes the expression of genes encoding glycolytic and lipogenic enzymes and suppresses genes encoding gluconeogenic enzymes (3).
###end p 9
###begin p 10
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
Insulin action is mediated by insulin receptors (IRs) on the plasma membranes of responsive cells (4). Activation of the IRs leads to transphosphorylation of tyrosine residues in the IR activation loop, which in turn leads to the enhanced ability of the IRs to phosphorylate target proteins, such as insulin receptor substrates (IRSs). Tyrosyl phosphorylated IRS proteins act as docking sites for several SH2 domain-containing proteins, including the p85 regulatory subunit of phosphatidylinositol 3-kinase. Phosphatidylinositol 3-kinase becomes activated upon binding to IRS proteins, and its phosphoinositide products facilitate the activation of downstream targets.
###end p 10
###begin p 11
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Metabolic syndrome, type 2 diabetes, and cardiovascular disease are complex disorders that are associated with obesity, aging, sedentary lifestyle, and genetic predisposition. A common feature of these disorders is the development of insulin resistance, resulting in decreased insulin-stimulated glucose uptake, failure to suppress hepatic glucose production, and accumulation of hepatic lipid. Although the detailed mechanism(s) underlying insulin resistance remain controversial (4-7), there is general agreement that impaired post-IR signaling is involved (8).
###end p 11
###begin p 12
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 678 680 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 681 683 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 877 879 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Recent data suggest that prolonged high-fat feeding in mice leads to increased endoplasmic reticulum (ER) stress in liver and adipose tissue and contributes to the development of insulin resistance (9). The ER is a site of secretory and membrane protein synthesis and modification (10). Upon disruption in either protein folding or modification within the ER, the unfolded protein response (UPR) is activated. The unfolded protein response activates signaling through three stress-sensing proteins found on the ER membrane: PKR-like eukaryotic initiation factor 2alpha kinase (PERK), inositol-requiring kinase-1alpha (IRE-1alpha), and activating transcription factor-6 (ATF-6) (11,12). The main purpose of the UPR is to counter the deleterious effects of ER stress, since prolongation of the ER stress response leads to apoptosis, inflammation, and hepatic lipid accumulation (13).
###end p 12
###begin p 13
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
Whole-body knockout studies of protein tyrosine phosphatase 1B (PTP1B) in mice established PTP1B as a key regulator of body mass and insulin sensitivity (14,15). PTP1B-/- mice are lean because of enhanced leptin sensitivity, are more insulin sensitive, and have enhanced muscle and liver IR phosphorylation. In addition, PTP1B-/- primary and immortalized fibroblasts exhibit decreased ER stress response through impaired IRE1 signaling, but the in vivo relevance of these observations is not clear (16).
###end p 13
###begin p 14
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
We recently generated tissue-specific PTP1B-/- mice and found the brain to be the primary site mediating the effects of PTP1B on body mass. Because mice with global PTP1B deficiency and brain-specific PTP1B-/- mice are lean, and leanness improves insulin sensitivity, it has been difficult to assess the direct role of PTP1B in insulin sensitivity. Furthermore, recent studies have implicated a brain-liver circuit in regulating insulin sensitivity, raising the possibility that peripheral insulin sensitivity may be mediated partly via neuronal circuits (17). Indeed, young female brain-specific PTP1B-/- mice are more insulin sensitive than controls, despite having comparable body weight (18).
###end p 14
###begin p 15
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 727 730 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
These studies raised the possibility that all of the insulin sensitivity seen in PTP1B-/- mice might be due to central effects. To begin to address this issue, we generated muscle-specific PTP1B-/- mice and found that, compared with controls, these mice exhibit significant improvement in whole-body glucose homeostasis on both chow and high-fat diet (HFD) despite comparable body weight and adiposity (19). In light of the critical role of the liver in glucose homeostasis and the pathogenesis of diabetes (5,13), and the potential role of PTP1B in the ER stress response (16), we asked whether PTP1B also has autonomous effects on hepatic control of glucose homeostasis and lipid metabolism by generating liver-specific PTP1B-/- mice.
###end p 15
###begin title 16
RESEARCH DESIGN AND METHODS
###end title 16
###begin title 17
Animal studies.
###end title 17
###begin p 18
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">Mice</span>
PTP1B floxed mice were generated previously (18). Alb-Cre mice on a 129Sv/C57Bl6 hybrid background were obtained from C. Ronald Kahn (Joslin Diabetes Center). All mice studied were age-matched littermate males on the mixed 129Sv/C57Bl6 background. Mice were maintained in a temperature-controlled barrier facility on a 12-h light/dark cycle with free access to water and food (19). Genotyping for the PTP1B floxed allele and the presence of Cre was performed by PCR (18).
###end p 18
###begin title 19
Body composition.
###end title 19
###begin p 20
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
Mice were placed on standard lab chow or HFD at weaning (21 days old), and weights were monitored weekly. Length was measured from nose to rump (cm). Fat pads were dissected from mice fed an HFD for 18 weeks and weighed individually (19).
###end p 20
###begin title 21
Metabolic measurements.
###end title 21
###begin p 22
###xml 116 120 116 120 <sc xmlns:xlink="http://www.w3.org/1999/xlink">a.m.</sc>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 478 481 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 519 520 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 579 581 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 587 589 587 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
Glucose in tail blood was assayed using a glucometer (Lifescan). Fed measurements were taken between 8:00 and 10:00 a.m. and, where indicated, from mice fasted for 12 h. Serum insulin and leptin were determined by ELISA (CrystalChem), and free fatty acids were quantified by enzymatic assay (Wako). Insulin tolerance tests (ITTs) and glucose tolerance tests (GTTs) were performed as described (18,19). A 2-h hyperinsulinemic-euglycemic clamp was conducted in awake Alb-Cre-PTP1B-/- mice (n = 15) and fl/fl littermates (n = 13) at a continuous insulin infusion rate of 2.5 mU . kg-1 . min-1, as described previously (19 and in the supplemental information, found in an online-only appendix at ).
###end p 22
###begin title 23
Biochemical studies.
###end title 23
###begin p 24
###xml 214 215 214 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 357 358 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 360 362 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 363 365 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 824 825 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 163 168 <span type="species:ncbi:10090">Mouse</span>
###xml 651 658 <span type="species:ncbi:9031">chicken</span>
For insulin signaling experiments, animals were fasted for 12 h, saline or insulin (10 mU/g) was injected intraperitoneally, and livers were removed 10 min later. Mouse tissues were dissected and frozen in liquid N2. Tissue lysates were prepared by extraction in radioimmunoprecipitation assay (RIPA) buffer at 4degreesC, followed by clarification at 14,000g (19,20). For immunoblots, proteins were resolved by SDS-PAGE and transferred to PVDF. Immunoblots were performed with polyclonal antibodies against pIR1162/1163 (Invitrogen), IRbeta (Santa Cruz), IRS-1/IRS-2 (Millipore), p85 (Millipore), phospho-GS-Ser641 (Cell Signaling), glycogen synthase chicken antibody (gift from the late Dr. John Lawrence, UVA), or PTP1B (Millipore). For ER stress experiments, the following antibodies, all from Cell Signaling, were used: p-p38, p38, pJNK, pPERK, peIF2a (Ser 51), and eIF2alpha. Proteins were visualized using enhanced chemiluminescence and quantified by scanning densitometry (Image J software). Phosphorylated IRS-1 in livers (2 mug protein) was detected by enzyme-linked immunosorbent assay (ELISA) (PathScan Phospho-IRS-1, Cell Signaling). For immunoprecipitation studies, IRS-1 or IRS-2 was immunoprecipitated from liver lysates (1 mg) with IRS-1 (Millipore) or IRS-2 antibody (Santa Cruz) and protein A Sepharose. Immunoprecipitates were washed four times with lysis buffer, subjected to SDS-PAGE, transferred to PVDF membranes, and immunoblotted with anti-phosphotyrosine antibody (Santa Cruz) or p85 antibody (Millipore). No differences in total IRS-1 or IRS-2 levels were detected.
###end p 24
###begin title 25
Gene expression analysis.
###end title 25
###begin p 26
###xml 469 482 465 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;&#948;&#948;Ct</sup>
###xml 578 579 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Liver RNA was isolated using Trizol (Invitrogen) and purified with the RNeasy kit (Qiagen). A total of 1 mug RNA was reverse-transcribed in 20 mul reaction volume with the Advantage RT-for-PCR kit (Clontech). Then 1-2 mul cDNA was used to amplify the target genes in the real-time RT-PCR (20 mul) using SYBR Green PCR Master Mix (ABI) followed by analysis using the Eppendorf Mastercycler ep Realplex. Relative gene expression was calculated using the comparative Ct (2-deltadeltaCt) method. The relative copy number of GAPDH and 18S was used for normalization (SABiosciences RT2 qPCR Primer Assays). PCRs were followed by melting curve (60-95degreesC) and agarose gel analysis to ensure specificity (for primer sequences and PCR conditions, see the supplemental information).
###end p 26
###begin title 27
Lipid analysis.
###end title 27
###begin p 28
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
Serum and liver triglycerides and cholesterol were measured at the Vanderbilt MMPC Lipid Core facility. Lipids were extracted using the method of Folch et al. (21), and individual lipid classes were separated by thin-layer chromatography and visualized by rhodamine 6G. Triglycerides were quantified as described (22). Cholesterol measurements were performed by gas chromatography as described (23).
###end p 28
###begin title 29
RESULTS
###end title 29
###begin title 30
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Generation of liver-specific PTP1B-/- mice.
###end title 30
###begin p 31
###xml 306 309 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 463 464 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 466 475 466 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 581 582 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 706 707 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 700 707 688 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 709 721 697 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
Mice with liver-specific PTP1B deletion were generated by crossing PTP1Bfl/fl mice to mice expressing Cre recombinase under the control of the albumin promoter (Alb-Cre). The resultant Alb-Cre PTP1B +/fl mice were crossed to PTP1Bfl/fl mice, yielding Alb-Cre PTP1Bfl/fl mice (hereafter termed Alb-Cre-PTP1B-/- mice), Alb-Cre PTP1B +/fl mice, and PTP1Bfl/fl controls (18). PCR for the deleted PTP1B allele confirmed that deletion occurred only in the liver (Fig. 1A, top panel). As expected, Alb-Cre-PTP1B-/- mice exhibited approximately80% reduction in PTP1B protein in the liver (1), consistent with hepatocyte-specific deletion. Other insulin-responsive tissues had normal levels of PTP1B protein (Fig. 1A, bottom panel).
###end p 31
###begin p 32
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 283 290 283 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 311 318 311 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 339 340 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 333 340 333 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Alb-Cre-PTP1B-/- and control mice were weaned onto either HFD (55% kcal from fat) or normal chow (4.5% fat). The absence of PTP1B in hepatocytes had no effect on body weight on either diet (Fig. 1B), as expected from previous studies (18). Adiposity, as assessed by fat pad weights (Fig. 1C) and leptin levels (Fig. 1D), and length (Fig. 1E), were unaffected by PTP1B deficiency. Hematoxylin and eosin staining of liver sections revealed no overt histological differences between Alb-Cre-PTP1B-/- and fl/fl control littermates (data not shown).
###end p 32
###begin title 33
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Improved glucose homeostasis in Alb-Cre-PTP1B-/- mice.
###end title 33
###begin p 34
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 290 297 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 305 306 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 299 306 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 322 325 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 530 531 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 536 537 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 524 537 512 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic> and <italic>C</italic></xref>
###xml 602 605 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 633 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 705 708 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 721 722 709 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 727 728 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 715 728 703 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic> and <italic>E</italic></xref>
###xml 734 744 722 732 <sc xmlns:xlink="http://www.w3.org/1999/xlink">discussion</sc>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
Compared with littermate controls, Alb-Cre-PTP1B-/- mice fed an HFD exhibited lower fed glucose levels at 8 weeks of age and lower fasted glucose, serum insulin levels, and insulin-to-glucose ratios at approximately16 weeks of age, indicating an overall improvement in glucose homeostasis (Table 1; Fig. 2A). Alb-Cre-PTP1B-/- mice also exhibited an enhanced ability to clear glucose from the peripheral circulation during intraperitoneal GTTs on either chow (8 weeks of age) or HFD (11 weeks of age) compared with controls (Fig. 2B and C). Insulin secretion during the GTTs was similar in Alb-Cre-PTP1B-/- and fl/fl controls (Table 1). In contrast to their improved GTTs, ITTs were normal in Alb-Cre-PTP1B-/- mice (Fig. 2D and E; see discussion).
###end p 34
###begin title 35
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Increased suppression of hepatic glucose production in Alb-Cre-PTP1B-/- mice.
###end title 35
###begin p 36
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 343 350 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 465 468 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 481 482 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 475 482 463 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 528 531 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 668 669 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 662 669 650 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 775 778 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 785 786 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 861 862 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 855 862 843 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 997 1000 985 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E&#8211;G</italic>
###xml 991 1000 979 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E&#8211;G</italic></xref>
###xml 1109 1112 1097 1100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
To assess whether improved glucose tolerance was due to autonomous effects of PTP1B deficiency in the liver, we performed hyperinsulinemic-euglycemic clamps in male Alb-Cre-PTP1B-/- and fl/fl control mice fed a chow diet. Hepatic glucose production during the insulin-stimulated state (clamp) was significantly lower in Alb-Cre-PTP1B-/- mice (Fig. 3A), resulting in approximately30% higher insulin-mediated suppression of hepatic glucose production in Alb-Cre-PTP1B-/- mice (Fig. 3B). Basal blood glucose levels in Alb-Cre-PTP1B-/- mice were similar to those in control littermates and were maintained at levels comparable to those of controls during the clamp (Fig. 3C). The glucose infusion rate required to maintain euglycemia during clamps trended higher in Alb-Cre-PTP1B-/- mice (P = 0.052), indicating an overall improvement in insulin sensitivity (Fig. 3D). Insulin-stimulated whole-body glucose turnover and glucose metabolism in skeletal muscle were similar between the two groups (Fig. 3E-G). These data suggest that improvement in whole-body glucose homeostasis, as measured by GTT in Alb-Cre-PTP1B-/- mice, is mostly due to increased insulin sensitivity in liver.
###end p 36
###begin title 37
Increased insulin signaling in liver lacking PTP1B.
###end title 37
###begin p 38
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 524 531 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 785 786 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 779 786 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 864 867 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 880 881 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 874 881 874 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 961 964 961 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1196 1199 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1212 1213 1212 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1206 1213 1206 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1299 1302 1299 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1454 1455 1454 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1448 1455 1448 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 1546 1549 1546 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 594 598 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
###xml 1303 1307 <span type="species:ncbi:10090">mice</span>
###xml 1550 1554 <span type="species:ncbi:10090">mice</span>
To investigate the molecular mechanism of improved hepatic insulin sensitivity in Alb-Cre-PTP1B-/- mice, we injected fasted, male Alb-Cre-PTP1B-/-, or fl/fl littermate control mice with insulin or saline (control) and examined insulin signaling in liver. We analyzed phosphorylation of Y1162/Y1163 on the insulin receptor because these sites are reported to be preferentially dephosphorylated by PTP1B (24,25). Insulin-stimulated IR phosphorylation was higher in Alb-Cre-PTP1B-/- mice on a chow diet compared with controls (Fig. 4A). High-fat feeding blunted hepatic insulin signaling in fl/fl mice, resulting in a less robust increase in insulin-induced IR phosphorylation. However, insulin-induced IR phosphorylation in Alb-Cre-PTP1B-/- liver was greater than in control mice (Fig. 4B). Basal IRS-1 tyrosine phosphorylation was increased in HFD-fed Alb-Cre-PTP1B-/- mice (Fig. 4C). Insulin-stimulated IRS-1 phosphorylation tended to be higher in Alb-Cre-PTP1B-/- mice, although this did not reach statistical significance. In contrast, basal tyrosine phosphorylation of IRS-2 was similar between the two groups, but insulin-stimulated IRS-2 phosphorylation was elevated in HFD-fed Alb-Cre-PTP1B-/- mice (Fig. 4D). Improved hepatic insulin signaling was also evident downstream, since Alb-Cre-PTP1B-/- mice exhibited higher insulin-stimulated IRS-1 and IRS-2 p85 association than controls, as well as reduced phosphorylation of glycogen synthase (Fig. 4E). These biochemical data suggest that the improved hepatic insulin action in Alb-Cre-PTP1B-/- mice is the direct result of increased IR signaling.
###end p 38
###begin p 39
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 360 363 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 423 424 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 417 424 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>F</italic></xref>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
Insulin regulates hepatic glucose metabolism in part by altering gene expression (8). Consistent with their improved glucose homeostasis, the levels of peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G-6-Pase) mRNA were significantly lower in Alb-Cre-PTP1B-/- mice fed an HFD for 18 weeks compared with controls (Fig. 4F).
###end p 39
###begin title 40
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Improved lipid homeostasis in Alb-Cre-PTP1B-/- mice.
###end title 40
###begin p 41
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 229 236 229 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 553 556 553 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 574 581 574 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
Because the liver plays a major role in lipid metabolism, we assessed several parameters of whole-body lipid homeostasis in Alb-Cre-PTP1B-/- and control mice. Serum free fatty acids were unchanged between the two groups of mice (Table 1). However, liver triglyceride levels were significantly lower in Alb-Cre-PTP1B-/- mice after 5 weeks of high-fat feeding (Fig. 5A), whereas this difference was not detectable at 18 weeks of HFD, probably due to very high levels of triglyceride at this time. Serum triglyceride levels were also lower in Alb-Cre-PTP1B-/- mice fed an HFD (Fig. 5B).
###end p 41
###begin p 42
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 768 771 768 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 784 785 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 778 785 778 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 922 925 922 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>E</italic></xref>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1265 1268 1265 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1325 1326 1325 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1319 1326 1319 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>F</italic></xref>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1269 1273 <span type="species:ncbi:10090">mice</span>
Lipid homeostasis in vertebrate cells is regulated by a small family of membrane-bound transcription factors, designated sterol regulatory element-binding proteins (SREBPs), which directly activate the expression of >30 genes dedicated to the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids (26). Analysis of the hepatic lipogenic genes SREBP1a and SREBP1c, and their target genes fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC), revealed a decrease in their mRNA levels in HFD-fed Alb-Cre-PTP1B-/- mice (Fig. 5C). Expression of genes involved in cholesterol synthesis, such as SREBP2 and its target gene 3-hydroxy-3-methylglutaryl-coenzyme A synthase 1 (HMGCS1), also were significantly decreased in HFD-fed Alb-Cre-PTP1B-/- mice (Fig. 5D). Consistent with their reduced SREBP2 and HMGCS1 expression, liver cholesterol levels were significantly lower in HFD-fed Alb-Cre-PTP1B-/- mice compared with controls (Fig. 5E). In fact, cholesterol levels in Alb-Cre-PTP1B-/- mice fed an HFD were similar to those measured in chow-fed mice (data not shown), suggesting that liver-specific PTP1B deletion protects against cholesterol accumulation caused by prolonged HFD feeding. Serum cholesterol levels in HFD-fed Alb-Cre-PTP1B-/- mice also were lower than in control littermates (Fig. 5F).
###end p 42
###begin title 43
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Decreased ER stress response in HFD-fed Alb-Cre-PTP1B-/- mice.
###end title 43
###begin p 44
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 479 482 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 662 665 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 736 737 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 742 743 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 730 743 726 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>A</italic> and <italic>B</italic></xref>
###xml 947 950 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1044 1045 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1038 1045 1034 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1083 1085 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1160 1161 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1154 1161 1150 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 951 955 <span type="species:ncbi:10090">mice</span>
###xml 1170 1174 <span type="species:ncbi:10090">mice</span>
###xml 1388 1392 <span type="species:ncbi:10090">mice</span>
Genetic and dietary obesity in mice induce the ER stress response, which is associated with insulin resistance and intracellular lipid accumulation (9). To investigate whether deficiency of PTP1B in liver protects against HFD-induced ER stress, we analyzed components of the ER stress response in livers of 18-week HFD-fed Alb-Cre-PTP1B-/- and control mice. PTP1B-/- fibroblasts reportedly have decreased phosphorylation of stress-activated p38 MAPK (16). Likewise, Alb-Cre-PTP1B-/- mice had decreased levels of p38 MAPK in their livers, but in addition, JNK, pPERK, and eIF2alpha phosphorylation was also reduced. Together, these data suggest that Alb-Cre-PTP1B-/- mice are more resistant to HFD-induced ER stress than controls (Fig. 6A and B). Consistent with this notion, expression of the pro-apoptotic transcription factor C/EBP homologous protein (CHOP), while substantially induced by prolonged high-fat feeding in control and Alb-Cre-PTP1B-/- mice, was significantly lower at the mRNA and protein level in PTP1B-deficient livers (Fig. 6C). As expected from in vitro studies (16), expression of XBP1s (a key factor in ER stress) was also reduced (Fig. 6D). Thus, mice lacking PTP1B in the liver are more resistant to obesity-induced ER stress, providing an additional potential mechanism by which glucose and lipid homeostasis after prolonged high-fat feeding is improved in these mice.
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
Metabolic syndrome, which is associated with hyperinsulinemia, hyperglycemia, and lipid abnormalities, often leads to diabetes and cardiovascular disease (27-29). Insulin resistance plays a key role in the pathophysiology of metabolic syndrome, resulting in decreased glucose metabolism, insulin action, and alterations in hepatic lipid metabolism. Whole-body knockout studies of mice showed that PTP1B is a major regulator of insulin sensitivity and body weight (14,15) and suggested that PTP1B might be a useful target for the therapy of diabetes and obesity. Here we found that mice lacking PTP1B selectively in the liver have improved glucose homeostasis and reduced levels of triglycerides and cholesterol, independent of changes in body weight or adiposity. These studies show that PTP1B has autonomous effects on both glucose and lipid metabolism in the liver and extend the potential utility of PTP1B inhibitors to the treatment of metabolic syndrome.
###end p 46
###begin p 47
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 627 630 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
The metabolic importance of hepatic insulin signaling was validated by mice with liver-specific deletion of the IR (LIRKO), which exhibit dramatic insulin resistance, severe glucose intolerance, and dysregulated hepatic gene expression (1). Alb-Cre-PTP1B-/- mice exhibit increased insulin-stimulated IR phosphorylation, as well as basal IRS-1 and insulin-stimulated IRS-2 tyrosine phosphorylation. Increased insulin-stimulated IR phosphorylation in these mice is in line with the known role of PTP1B as a negative regulator of IR signaling (14,15), whereas the elevation of basal IRS-1 tyrosine phosphorylation in Alb-Cre-PTP1B-/- mice in the absence of increased basal IR phosphorylation is consistent with previous studies showing that PTP1B also can dephosphorylate IRS-1 directly in vitro (30).
###end p 47
###begin p 48
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 473 476 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 530 532 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 677 679 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 747 749 735 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 750 752 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 837 839 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 840 842 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 1005 1008 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 871 876 <span type="species:ncbi:10090">mouse</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
Insulin signaling suppresses gluconeogenic gene expression. Notably, IRS-1 and IRS-2 have complementary roles in the liver, with IRS-1 more closely linked to glucose homeostasis and IRS-2 more important for lipid metabolism (31). Knockdown of IRS-1 in the livers of wild-type mice results in upregulation of G-6-Pase and PEPCK. Consistent with increased IR and IRS-1 tyrosine phosphorylation, we observe decreased expression of G-6-Pase and PEPCK in livers of Alb-Cre-PTP1B-/- mice. The PGC-1alpha promoter is activated by FoxO1 (32). Insulin suppresses PGC-1alpha gene expression by promoting Akt phosphorylation and subsequent phosphorylation and nuclear exclusion of FoxO1 (33). PGC-1alpha expression is elevated in livers of insulin-resistant ob/ob and LIRKO mice, confirming a key role for insulin as a suppressor of PGC-1 in vivo (34,35). As would be expected in a mouse model with enhanced hepatic insulin sensitivity, we observe decreased expression levels of PGC-1alpha in livers of Alb-Cre-PTP1B-/- mice.
###end p 48
###begin p 49
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
Alb-Cre-PTP1B-/- mice show enhanced ability of insulin to suppress hepatic glucose production and increased hepatic insulin signaling. Alb-Cre-PTP1B-/- mice also exhibit enhanced ability to clear glucose from the peripheral circulation during GTTs; however, ITTs are similar between Alb-Cre-PTP1B-/- and control mice. Muscle and liver have different "set-points" for insulin action, with higher doses required to stimulate glucose uptake into muscle than to suppress hepatic glucose production. The comparable ITTs in Alb-Cre-PTP1B-/- and control animals are probably due to the relatively high insulin doses used for ITTs, which results in complete suppression of hepatic glucose production.
###end p 49
###begin p 50
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 874 877 874 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1027 1030 1027 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1214 1217 1214 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1237 1239 1237 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 1240 1242 1240 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob</italic>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 1657 1659 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 587 591 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1218 1222 <span type="species:ncbi:10090">mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
###xml 1453 1457 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
In addition to its effects on glucose homeostasis, insulin regulates hepatic lipid metabolism by altering lipogenic gene transcription. High insulin levels persistently activate SREBP1c transcription and cleavage, even after patients become "insulin resistant" at the level of gluconeogenesis (26). This leads to increased lipogenic gene expression and accelerated triglyceride accumulation in the liver (36-38). Confirming the importance of the insulin receptor in mediating these effects, LIRKO mice have low serum triglyceride levels and decreased SREBP1c gene expression (29). LIRKO mice, however, also have 10-fold higher circulating leptin levels (39), and leptin has been suggested to play a role in regulation of glucose homeostasis (40) and plasma triglycerides (41). Surprisingly, SREBP1c and SREBP1a gene expression levels are significantly lower in Alb-Cre-PTP1B-/- mice than in controls. This is opposite to what would be expected from the LIRKO phenotype and the enhanced insulin sensitivity seen in Alb-Cre-PTP1B-/- mice. Consistent with their decreased SREBP1 expression, expression of the SREBP target genes FAS and acetyl-CoA carboxylase and serum triglyceride levels are reduced in Alb-Cre-PTP1B-/- mice. Treatment of ob/ob mice with PTP1B oligonucleotides resulted in a similar decrease in lipogenic gene expression, including SREBP1 (38). Furthermore, a study in which high-fructose feeding was used to induce insulin resistance in rats reported a direct association between increased hepatic expression of SREBP1c and PTP1B and suggested a novel mechanism by which PTP1B regulates SREBP1c expression levels by enhancing PP2A activity (43). We therefore suspect that PTP1B may affect SREBP1 gene expression via a pathway distinct from the insulin signaling; however, further work is required to clarify the precise mechanism.
###end p 50
###begin p 51
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 706 709 706 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 794 797 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
Reduced expression of lipogenic genes in livers of Alb-Cre-PTP1B-/- mice, as well as lower triglyceride, is most likely the direct result of decreased levels of SREBP. Although recent studies of LIRKO mice emphasize the importance of insulin in regulating hepatic lipid balance, for the reasons discussed above, the effects of hepatic PTP1B deficiency on lipid homeostasis cannot be directly attributed to improved insulin action. Previous studies indicate that PTP1B also regulates growth hormone (GH) signaling (44), and GH has been shown to normalize serum triglyceride and cholesterol levels in aged rats (45). We cannot exclude the possibility that hepatic GH signaling may be altered in Alb-Cre-PTP1B-/- mice, although we did not observe differences in linear growth between Alb-Cre-PTP1B-/- and control mice.
###end p 51
###begin p 52
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r47">47</xref>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r48">48</xref>
###xml 173 179 <span type="species:ncbi:9606">humans</span>
###xml 455 459 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 751 755 <span type="species:ncbi:10090">mice</span>
Insulin resistance can lead to hepatic fat accumulation, even in the absence of obesity, as evidenced by the prevalence of nonalcoholic fatty liver disease in normal-weight humans. Recent studies have shown that hepatic cholesterol, rather than hepatic triglyceride, may play an important role in the pathogenesis of nonalcoholic fatty liver disease (46). Free cholesterol (but not free fatty acids or triglyceride) accumulation in hepatocytes sensitizes mice to TNF- or Fas-induced fatty liver (47). LIRKO mice fed a high-fat "Western" diet (40% fat) develop marked hypercholesterolemia, whereas consumption of an atherogenic diet (15% fat, 1% cholesterol, 0.5% cholic acid) produces hypercholesterolemia and severe atherosclerosis. Alb-Cre-PTP1B-/- mice have lower expression of genes involved in cholesterol synthesis, including SREBP2 and HMGCS1, as well as decreased serum and liver cholesterol levels on a high-fat diet. High-fat feeding increases PTP1B expression in the liver (48), raising the intriguing possibility that PTP1B deficiency/inhibition in the liver may protect against the progression of fatty liver disease. How liver-specific deficiency of PTP1B results in decreased SREBP2 expression awaits further studies.
###end p 52
###begin p 53
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ob/ob</italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 536 538 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 598 600 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 886 887 874 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 911 912 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Recent studies demonstrated that HFD-feeding and genetic obesity (ob/ob) in mice induces the ER stress response (9), leading to cell death, inflammation, insulin resistance, and intracellular lipid accumulation. PERK is an ER transmembrane protein kinase that phosphorylates the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha) in response to ER stress, and the phosphorylation status of PERK and eIF2alpha is therefore a key indicator of ER stress. Examination of downstream markers for ER stress, such as CHOP (13), a b-ZIP transcription factor that potentiates apoptosis (11), or spliced XPB1, which plays a key role in the ER stress response by regulating the transcription of an array of genes, provides an additional readout of these ER stress pathways. Furthermore, ER stress-evoked signaling downstream of IRE1 leads to activation of p38 MAPK and c-Jun NH2-terminal kinase (JNK) (9).
###end p 53
###begin p 54
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 311 314 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 551 554 547 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
Studies performed on PTP1B-/- primary and immortalized fibroblasts revealed that the absence of PTP1B protects against ER stress response (16). We found that Alb-Cre-PTP1B-/- livers are more resistant to HFD-induced ER stress response. Phosphorylation of p38 was significantly lower in livers from Alb-Cre-PTP1B-/- mice compared with controls, as was phosphorylation of JNK, PERK, and eIF2alpha, suggesting that liver PTP1B deficiency causes impaired ER stress-induced IRE1 signaling. CHOP and XBP1s levels also were decreased in HFD-fed Alb-Cre-PTP1B-/- mice, consistent with impaired ER stress-induced PERK signaling. These in vivo studies demonstrate for the first time that PTP1B deficiency affects multiple "arms" of the ER stress response.
###end p 54
###begin p 55
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r49">49</xref>
###xml 912 915 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
Overall, our findings demonstrate that PTP1B plays a critical role in hepatic glucose and lipid metabolism. Selective enhancement of insulin signaling in the liver would normally be expected to suppress gluconeogenesis, while enhancing lipogenesis and fat accumulation in the liver. Alb-Cre-PTP1B-/- mice represent a model of "selective" insulin hypersensitivity, whereby gluconeogenic gene expression is suppressed and glucose homeostasis is improved, whereas triglyceride and cholesterol levels are improved as well. Our previous studies showed that inhibiting neuronal PTP1B is critical for conferring the beneficial effects of PTP1B deficiency on body mass/adiposity (18). Because of technical limitations in designing specific, bioavailable PTP1B inhibitors, the brain may be particularly difficult to target for therapy (49). The current results, combined with our previous studies of muscle-specific PTP1B-/- mice (19), indicate that inhibiting PTP1B in the periphery should result in improved insulin sensitivity. Furthermore, inhibition of PTP1B in liver would have a beneficial lipid-lowering effect. Thus, PTP1B inhibitors may be an attractive therapy for use in the treatment of metabolic syndrome and cardiovascular risk, in addition to insulin resistance and diabetes.
###end p 55
###begin title 56
Supplementary Material
###end title 56
###begin title 57
Online-Only Appendix
###end title 57
###begin p 58
###xml 873 878 <span type="species:ncbi:10090">Mouse</span>
###xml 921 926 <span type="species:ncbi:10090">Mouse</span>
This work was supported by National Institutes of Health (NIH) Grants DK 60838 (to B.B.K. and B.G.N.), DK 60839 (to B.B.K.), R37 CA49152 (to B.G.N.), and U24-DK59635 (to J.K.K.); the Physiology Core Grant DK57521 (to B.B.K.); and a Research Grant from the American Diabetes Association (to B.G.N.). M.D. was the recipient of a postdoctoral fellowship from the American Heart Association and is currently supported by Research Councils UK Fellowship, Diabetes UK project grant, and the Royal Society Research Grant. K.K.B. was supported by a Penn Center for Molecular Studies in Digestive and Liver Disease Pilot Grant (DK50306), University of Pennsylvania Research Foundation, and the USDA (Section 1433 Animal Health and Disease Formula Grant). Lipid analysis was performed at the Vanderbilt MMPC Lipid Core (DK59637). Parts of this study were performed at the Penn State Mouse Metabolic Phenotyping Center and the Yale Mouse Metabolic Phenotyping Center, and the study was supported by grants from the American Diabetes Association (1-04-RA-47 to J.K.K.) and the Pennsylvania State Department of Health (to J.K.K.).
###end p 58
###begin p 59
B.G.N. and B.B.K. have equity in Ceptyr Inc, a company trying to develop PTP1B inhibitors, and B.B.K. also serves on its Scientific Advisory Board. No other potential conflicts of interest relevant to this article were reported.
###end p 59
###begin p 60
###xml 65 69 <span type="species:ncbi:10090">mice</span>
We thank C. Ronald Kahn (Joslin Diabetes Center) for the Alb-Cre mice.
###end p 60
###begin title 61
REFERENCES
###end title 61
###begin p 62
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 181 184 181 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 502 513 502 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 677 678 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 711 714 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 716 717 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 740 743 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 750 751 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 778 779 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 832 836 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 870 873 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 875 876 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 903 904 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 951 956 939 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 959 960 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1006 1009 994 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1011 1012 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1036 1039 1024 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1041 1042 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1064 1065 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1187 1188 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1228 1231 1216 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1233 1234 1221 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1256 1257 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1293 1296 1281 1284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1298 1299 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1322 1323 1310 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1359 1360 1347 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1390 1393 1378 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1395 1396 1383 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1412 1415 1400 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1417 1418 1405 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1440 1441 1428 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 1058 1062 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
###xml 1316 1320 <span type="species:ncbi:10090">mice</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
Liver-specific PTP1B deletion has no effect on body weight or adiposity. A: Deletion efficiency, as detected by PCR and Western blotting, in the indicated tissues from Alb-Cre-PTP1B-/- and fl/fl littermates. PCR was performed on DNA isolated from Alb-Cre-PTP1B-/- tissues: P, pituitary; B, brain; L, liver; M, gastrocnemius muscle; S, spleen; H, heart; W, abdominal white adipose tissue; K, kidney; and L, lung. "-" and "+" represent negative and positive controls, respectively. The immunoblot in the lower panel indicates approximately80% deletion of PTP1B protein in liver, consistent with deletion from hepatocytes, which comprise that approximate percentage of the liver. B: Weight curves for Alb-Cre-PTP1B-/- (n = 6) and Alb-Cre-PTP1B+/- mice (n = 10) vs. fl/fl controls (n = 16) on chow diet from weaning to 17 weeks of age (left). Weight curves for Alb-Cre-PTP1B-/- (n = 12) and fl/fl controls (n = 12) on HFD from weaning to 19 weeks of age (right). C: Fat pad weights of 19-week-old Alb-Cre-PTP1B-/- (n = 12) and Alb-Cre-PTP1B+/- (n = 9) vs. fl/fl mice (n = 12) on HFD. BAT, brown adipose tissue; EPI, epididymal; MES, mesenteric; RP, retroperitoneal; and SUB Q, subcutaneous. D: Leptin levels (ng/ml) in Alb-Cre-PTP1B-/- (n = 5) and fl/fl mice (n = 9) on chow diet and Alb-Cre-PTP1B-/- (n = 10) and fl/fl mice (n = 12) on HFD (at 5 months of age). E: Length (cm) of Alb-Cre-PTP1B-/- (n = 12) and PTP1B+/- (n = 9) vs. fl/fl mice (n = 12) on HFD.
###end p 62
###begin p 63
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 680 681 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 785 786 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 811 814 811 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
Improved glucose homeostasis in Alb-Cre-PTP1B-/- mice. A: Insulin-to-glucose ratio in male Alb-Cre-PTP1B-/- (n = 13), Alb-Cre PTP1B+/- (n = 8), and fl/fl (n = 14) mice on HFD at 8 and 16 weeks of age, respectively. B: GTTs on male Alb-Cre-PTP1B-/- (n = 6), Alb-Cre PTP1B+/- (n = 6), and fl/fl control mice (n = 8) on chow diet at 8 weeks of age. C: GTTs on male Alb-Cre-PTP1B-/- (n = 6), Alb-Cre PTP1B+/- (n = 8), and fl/fl mice (n = 8) on HFD for 8 weeks (11 weeks of age). D: ITTs on male Alb-Cre-PTP1B-/- (n = 6), Alb-Cre PTP1B+/- (n = 6), and fl/fl mice (n = 8) on chow diet at 8 weeks of age (insulin dose 0.75 mU/g). E: ITTs on male Alb-Cre-PTP1B-/- (n = 6) and fl/fl mice (n = 8) on HFD for 7 weeks (10 weeks of age) (insulin dose 1 mU/g). Data were analyzed by two-way ANOVA (*P < 0.05 for Alb-Cre-PTP1B-/- vs. fl/fl).
###end p 63
###begin p 64
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 201 228 201 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 341 342 341 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 608 609 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 617 618 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 628 629 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Hyperinsulinemic-euglycemic clamp studies. Alb-Cre-PTP1B-/- (n = 15) and fl/fl control (n = 13) mice on chow diet at 18-20 weeks of age were subjected to hyperinsulinemic-euglycemic clamp studies (see research design and methods). A: Hepatic glucose production. B: Hepatic insulin action (percent suppression of hepatic glucose production). C: Basal and clamp blood glucose levels. D: Whole-body glucose infusion rate. E: Whole-body glucose turnover. F: Whole-body glycogen and lipid synthesis. G: Glucose uptake into gastrocnemius muscle. Results are mean +/- SE. Data were analyzed by one-tailed Student's t test (*P < 0.05; #P = 0.052).
###end p 64
###begin p 65
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 582 585 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 602 603 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 628 631 628 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;D</italic>
###xml 714 715 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 725 726 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1043 1044 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1217 1220 1217 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1222 1223 1222 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1253 1254 1253 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1360 1361 1358 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1369 1370 1367 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1381 1382 1379 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
###xml 800 804 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
Enhanced insulin sensitivity in Alb-Cre-PTP1B-/- mice. A and B: Insulin receptor phosphorylation on Y1162/1163 in livers of 18-week-old male mice on chow (A) or HFD (B) and injected with saline or insulin (10 mU/g i.p.). C: IRS-1 tyrosine phosphorylation in liver as measured by ELISA in 18-week-old mice on HFD. D: IRS-2 tyrosine phosphorylation in liver of 18-week-old mice on HFD, quantified by IRS-2 immunoprecipitation and anti-phosphotyrosine immunoblotting. Bar graphs represent pooled, normalized data to total amount of IRS protein (arbitrary units [AU]) from Alb-Cre-PTP1B-/- and fl/fl mice (n = 6-8 per group). Data (A-D) were analyzed by one-way ANOVA, followed by a Tukey's multiple comparison test (*P < 0.05). E: IRS-1 and IRS-2 were immunoprecipitated from liver lysates (18-week-old mice on HFD) and immunoblotted for the p85 regulatory subunit of phosphatidylinositol 3-kinase. Liver lysates from 18-week-old mice on HFD were also immunoblotted for total levels of p85, phospho-glycogen synthase (GS), and glycogen synthase. F: Relative expression of PGC1, PEPCK, and G-6-Pase mRNAs, normalized against 18S mRNA levels, measured by quantitative real-time PCR in livers from fasted male Alb-Cre-PTP1B-/- (n = 6) and fl/fl control mice (n = 6) fed HFD for 18 weeks. Results are the means +/- SE; data were analyzed using a two-tailed Student's t test (*P < 0.05, **P < 0.01).
###end p 65
###begin p 66
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 219 220 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 506 509 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 511 512 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 682 683 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 691 692 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 703 704 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 771 774 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
Improved lipid metabolism in Alb-Cre-PTP1B-/- mice. Liver triglycerides (A) or serum triglycerides (B) are shown for male Alb-Cre-PTP1B-/- (n = 8) and control (n = 8) mice fed HFD for the indicated time in weeks. C and D: Relative mRNA levels, measured by quantitative real-time PCR normalized against 18S mRNA, in livers from male Alb-Cre-PTP1B-/- (n = 8) and fl/fl control mice (n = 8) fed HFD for 15 weeks (18 weeks of age) and fasted overnight. Liver (E) and serum (F) cholesterol in male Alb-Cre-PTP1B-/- (n = 8) and fl/fl control mice (n = 8) on HFD for 15-17 weeks (18-20 weeks of age) is shown. Results represent the means +/- SE. Data were analyzed by two-tailed Student's t test (*P < 0.05, **P < 0.01). blacksquare, square, filled, fl/fl; square, Alb-Cre PTP1B-/-.
###end p 66
###begin p 67
###xml 13 16 13 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 559 562 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 579 580 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 629 630 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 654 655 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 762 765 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 767 768 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 798 799 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 954 955 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1047 1048 1037 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1056 1057 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1068 1069 1058 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 825 829 <span type="species:ncbi:10090">mice</span>
Alb-Cre-PTP1B-/- mice are resistant to HFD-induced ER stress. A and B: Liver lysates from mice fed HFD for 18 weeks were analyzed by immunoblotting for p38 MAPK, JNK, PERK, and eIF2alpha phosphorylation. Blots were stripped and re-probed with total p38 antibodies. JNK, PERK, and eIF2alpha levels could not be assessed on re-probes, so the same samples were resolved on a parallel gel and immunoblotted for total levels. All immunoblots were quantified by densitometry (Image J). Bar graphs represent pooled data (% difference from control) from Alb-Cre-PTP1B-/- and fl/fl mice. C: Expression of CHOP mRNA at 5 and 18 weeks HFD (C) XBP1 at 18 weeks HFD (D) were measured by quantitative real-time PCR and normalized to 18S expression in livers from Alb-Cre-PTP1B-/- (n = 6) and fl/fl control mice (n = 6). Liver lysates from mice fed HFD for 18 weeks were also analyzed by immunoblotting for total levels of CHOP protein, and these blots are included in C. Results represent the means +/- SE, and significance was assessed by two-tailed Student's t test (*P < 0.05, **P < 0.01).
###end p 67
###begin p 68
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Blood glucose, serum insulin, plasma free fatty acids, and liver glycogen were analyzed in male PTP1B fl/fl control and Alb-Cre-PTP1B-/- mice (n = 6-18 mice/group) fed chow or HFD as indicated
###end p 68
###begin p 69
###xml 64 65 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Data are means +/- SE and were analyzed by two-tailed Student's t test.
###end p 69
###begin p 70
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.01,
###end p 70
###begin p 71
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P <0.05 for the indicated genotype compared with PTP1B fl/fl control littermates. ND, not determined.
###end p 71

